Coronary revascularisation in chronic kidney disease. Part II: acute coronary syndromes

Mike Seddon1, Nick Curzen

  • 1Wessex Cardiac Unit, Southampton University Hospitals NHS Trust, Tremona Road, Southampton SO16 6YD, UK.

Insights

Patients with chronic kidney disease (CKD) face complex cardiovascular challenges. This review examines coronary revascularization strategies for CKD patients experiencing acute coronary syndromes, highlighting potential benefits despite management complexities.

Area of Science:

  • Cardiology
  • Nephrology
  • Internal Medicine

Background:

  • Chronic kidney disease (CKD) significantly increases the risk of coronary artery disease (CAD), myocardial infarction, and cardiovascular mortality.
  • Managing acute coronary syndromes (ACS) in CKD patients presents unique challenges, including diagnostic uncertainty and limited evidence for interventions.
  • Despite complexities, CKD patients may benefit substantially from standard coronary revascularization approaches used in the general population.

Purpose of the Study:

  • To review current evidence on treating CKD patients with ACS.
  • To specifically evaluate the role and effectiveness of coronary revascularization strategies in this high-risk population.

Main Methods:

  • Systematic review of existing literature.
  • Analysis of studies focusing on coronary revascularization in CKD patients with ACS.
  • Synthesis of evidence regarding therapeutic interventions and adverse effects.

Main Results:

  • CKD patients with ACS have a higher burden of cardiovascular disease.
  • Diagnostic and therapeutic decisions are complicated by CKD and potential adverse effects of treatments.
  • Evidence suggests potential benefits of revascularization strategies, though specific data for CKD populations are often limited.

Conclusions:

  • Coronary revascularization strategies warrant careful consideration in CKD patients with ACS.
  • Further research is needed to establish optimal treatment guidelines for this complex group.
  • Balancing potential benefits against risks is crucial for managing ACS in the CKD population.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...